Takero Hirata
Papers
2
Total Citations
18
H-Index
2
About
Dr. Takero Hirata is a leading figure in medical physics and radiation oncology, whose work is fundamentally advancing the precision and efficacy of stereotactic ablative body radiotherapy (SABR). His research centers on two critical pillars: the meticulous dosimetry of small radiation fields and the development of innovative treatment strategies for challenging tumors. Dr. Hirata’s major contributions include a rigorous evaluation of calibration methods for the Exradin W2 plastic scintillation detector in CyberKnife systems, a study that has garnered 11 citations for its vital role in ensuring the accuracy of small-field dose measurements. Building on this technical foundation, he has pioneered a novel SABR approach for metastatic lung tumors that delivers a central high dose using the CyberKnife’s unique robotic platform. This work, cited 7 times, demonstrates how leveraging the system’s ability to create steep dose gradients from hundreds of beam angles can safely escalate the dose to the gross tumor volume. Dr. Hirata’s combined expertise in dosimetric validation and clinical innovation is setting new standards for high-precision radiotherapy, directly improving treatment outcomes for patients with complex cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2